Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
about
Management of refractory ascites in cirrhosis: Are we out of date?Vasopressin deficiency and vasodilatory state in end-stage liver disease.Penicillar arterioles of red pulp in residual spleen after subtotal splenectomy due to splenomegaly in cirrhotic patients: a comparative study.Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosisDecompensated liver cirrhosis and neural regulation of mesenteric vascular tone in rats: role of sympathetic, nitrergic and sensory innervations.Splanchnic vasodilation and hyperdynamic circulatory syndrome in cirrhosis.Extrahepatic complications to cirrhosis and portal hypertension: haemodynamic and homeostatic aspectsSimultaneous inhibition of TXA(2) and PGI(2) synthesis increases NO release in mesenteric resistance arteries from cirrhotic rats.H2 S inhibits the activation of hepatic stellate cells and downregulates the expression of urotensin II.Long-term portal hypertension increases the vasodilator response to acetylcholine in rat aorta: role of prostaglandin I2.Effect of short- and long-term portal hypertension on adrenergic, nitrergic and sensory functioning in rat mesenteric artery.Effect of TIPS placement on portal and splanchnic arterial blood flow in 4-dimensional flow MRI.Non-selective β-blockers improve the correlation of liver stiffness and portal pressure in advanced cirrhosis
P2860
Q28066017-FE8B5E7B-3F88-417A-960F-5CEF099B67B3Q35118679-C3A5A54C-19F6-4D77-BC54-43E8EADEC9D7Q35144976-93AB9E11-CB7E-4C4D-B73E-AB0C9BFC280CQ36875004-07EB62A3-43CF-4812-99DA-5FC42D2648D8Q37147861-7BD26B17-6AEE-45AF-88CB-4D934A502665Q38195834-62760EE3-3C07-45D2-9A7A-106221C552E7Q38268612-45AF65CE-008A-492A-9879-7378154E1D08Q43066566-0C5537FA-DFC1-4D84-8F48-A597CD2211D2Q45841710-4EFE8BB6-0FBC-4936-82DF-F1204693C3C8Q46069219-795EB45E-F106-4A6D-874F-807C0706D08EQ48222280-9782EBB3-EB9D-4599-8D0F-B6D0873BDB8DQ53551844-152D6C32-338E-45E1-ADD8-ED7082065313Q57168150-7792D6AD-0387-48C6-A7E0-CC78260AB021
P2860
Vasoactive factors and hemodynamic mechanisms in the pathophysiology of portal hypertension in cirrhosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2007
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@en
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@nl
type
label
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@en
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@nl
prefLabel
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@en
Vasoactive factors and hemodyn ...... tal hypertension in cirrhosis.
@nl
P921
P1476
Vasoactive factors and hemodyn ...... rtal hypertension in cirrhosis
@en
P2093
Angelo Gatta
Carlo Merkel
P304
P356
10.1016/J.MAM.2007.09.006
P577
2007-10-24T00:00:00Z